Silvant Capital Management’s Boston Scientific BSX Stock Holding History

Silvant Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$691K	Buy	11,011 +1,024	+10%	+$81.9K	0.02%	162
2025 Q4	$952K	Buy	9,987 +59	+0.6%	+$5.78K	0.03%	152
2025 Q3	$969K	Buy	9,928 +1,196	+14%	+$124K	0.03%	151
2025 Q2	$938K	Sell	8,732 -34,028	-80%	-$3.44M	0.04%	148
2025 Q1	$4.31M	Hold	42,760	–	–	0.2%	65
2024 Q4	$3.82M	Hold	42,760	–	–	0.16%	80
2024 Q3	$3.58M	Sell	42,760 -34,752	-45%	-$2.74M	0.16%	86
2024 Q2	$5.97M	Hold	77,512	–	–	0.26%	54
2024 Q1	$5.31M	Hold	77,512	–	–	0.25%	62
2023 Q4	$4.48M	Hold	77,512	–	–	0.24%	65
2023 Q3	$4.09M	Hold	77,512	–	–	0.25%	63
2023 Q2	$4.19M	Hold	77,512	–	–	0.24%	72
2023 Q1	$3.88M	Hold	77,512	–	–	0.25%	73
2022 Q4	$3.59M	Sell	77,512 -803	-1%	-$34.8K	0.25%	78
2022 Q3	$3.03M	Buy	+78,315	New	+$3.14M	0.21%	84

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Silvant Capital Management's BSX Position: Q1 2026 in Review

Silvant Capital Management increased its Boston Scientific (BSX) stake by 10% in Q1 2026, buying an estimated $81.9K and bringing the position to 11,011 shares worth $691K. The position accounts for 0.02% of the portfolio, ranked #162.

Silvant Capital Management first reported a position in BSX in Q3 2022 and has held it in 15 quarters since. The position peaked at $5.97M in Q2 2024. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Silvant Capital Management held 11,011 shares of Boston Scientific worth $691K as of Q1 2026.
Silvant Capital Management bought 1,024 Boston Scientific shares in Q1 2026, an estimated $81.9K.
Boston Scientific made up 0.02% of Silvant Capital Management's portfolio in Q1 2026, its #162 holding.
Silvant Capital Management first reported a position in Boston Scientific in Q3 2022 and has held it in 15 quarters since.
Silvant Capital Management's Boston Scientific position peaked at $5.97M in Q2 2024.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Silvant Capital Management's 13F filing for Q1 2026, filed 14 May 2026.